Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...

A medical device company has secured investment from the owner of the developer of Ozempic and a private equity firm, to ...

Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.

Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites ("the Company"), an international ...

Additional investment and resources will accelerate Biocomposites' international expansion and innovation in products for use in infection management HELLERUP, Denmark, LONDON and KEELE ...

Egnyte provides businesses with cloud-based content intelligence, governance, and collaboration tools through a unified intelligent content platform. The company’s solutions integrate AI, file storage ...

The company’s founders, management team, and existing investors, which include Springcoast, GV, Polaris, and Kleiner Perkins, will retain significant ownership in Egnyte.

Van ECK Associates Corp boosted its stake in TransAlta Co. (NYSE:TAC – Free Report) (TSE:TA) by 7.5% in the fourth quarter, ...

Bellevue, Wash.-based health software company Edifecs announced has agreed to be acquired by Cotiviti, a Utah-based healthcare giant backed by private equity firms. Terms of the deal were not ...